Gene therapy in lipid metabolism and CVD

Sekar Kathiresan is the Chief Executive Officer and founder of Verve Therapeutics, US. Previously, he was a Professor of Medicine at Harvard Medical School and the Director of the Center for Genomic Medicine in Boston, USA.

As a leading researcher in the field of the genetic background of cardiovascular disease, his work has enhanced the understanding of the inherited basis for blood lipids and myocardial infarction. In recent years, gene therapy has become a reality for several monogenic diseases.

In this lecture, he will explore the recent advances in gene therapy for treating dyslipidemia to prevent heart attacks.

Sekar Kathiresan

MD, cardiologist, co-founder and CEO of Verve Therapeutics

Cookies
We use cookies. If you think that's OK, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. You can change your settings from our Cookie Policy page.
Save Accept all

Report

Contains abusive or derogatory content
Contains mature or sensitive content
Contains misleading or false information
Contains spam, fake content or potential malware
Harassment or bullying behavior

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .